Unilife to Hold Special Shareholders Meeting on February 8, 2011

YORK, Pa., Jan. 25, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (Nasdaq: UNIS; ASX: UNS) today advised that it will hold a special meeting of stockholders in Sydney, Australia on Tuesday 8th February 2011 at 10:30 a.m. AEDT at the Radisson Plaza Hotel, 27 O'Connell Street (6:30 p.m. U.S. Eastern Standard Time on Monday 7th February 2011).

Mr. Jim Bosnjak OAM, Chairman of Unilife will host the meeting, with CEO Alan Shortall and other members of the Board of Directors expected to be available via teleconference.

"I encourage all shareholders to exercise their right to vote at this upcoming meeting," Mr. Bosnjak said. "It is very important that Unilife achieves a quorum of one-third of all outstanding shares of common stock for the meeting to be considered valid. If we do not secure this quorum, which is a requirement under U.S. laws and regulations, the meeting must be rescheduled to a later date. To avoid the cost and inconvenience of rescheduling, I urge all shareholders who are yet to cast a vote to review the meeting documents and utilize the fast and convenient voting systems that are in place. Shareholders with questions regarding this meeting should call either our Investor Hotline on the numbers listed below, or Computershare if they are missing or have lost their proxy materials."

All shareholders should have already received a Notice of Internet Availability of Stockholder Meeting Materials.  There are two separate voting procedures depending whether the shareholder holds CDIs (traded on the ASX) or common stock (traded on the NASDAQ).

CDI Holders

CDI holders should have already received a CDI Voting Instruction Form along with the Notice of Internet Availability. All proxy materials, including the Proxy Statement, are available online at www.investorvote.com.au with the use of control number 134775. CDI holders who wish to receive a hard copy of the Proxy Materials can request this from either the above website, or by calling 1300 557 010. Requests for a paper copy of the Proxy Materials must be received by Friday 28th January 2011.

Completed CDI Voting Instruction Forms must be received by Computershare by 12 p.m. (AEDT) on Wednesday 2nd February 2011 (8 p.m. Tuesday 1st February 2011 U.S. Eastern Standard Time).  Forms may be submitted online at www.investorvote.com.au, by fax at 1800 783 447 (within Australia) or +61 3 9473 2555 (outside Australia), or by post to Computershare Investor Services Pty Limited, GPO Box 242, Melbourne, VIC, 3001, Australia.

Common Stockholders

Common stockholders should have already received their individual control number on the Notice of Internet Availability. Common stockholders have not been sent a proxy card.  They may view the proxy materials and vote on-line at www.envisionreports.com/UNIS.  Common stockholders wishing to receive a hard copy of the Proxy Materials can request this from www.envisionreports.com/UNIS, by calling 1-866-641-4276, or by e-mailing a request to [email protected] with "Proxy Materials Unilife Corporation" in the subject line.  Requests for a paper copy of the Proxy Materials must be received by Friday 28th January 2011.

Common stockholders may vote by internet at www.envisionreports.com/UNIS or by telephone at 1-800-652-VOTE (8683).  All common stockholder votes must be received by Computershare by 12:00 p.m. U.S. Eastern Standard Time on Monday 7th February 2011.  Instructions for voting by mail will be included with any request for a paper copy of the Proxy Materials.

Unilife is a Delaware-registered company with bylaws requiring a minimum of one-third of all outstanding shares of common stock (including shares underlying the CDIs) to be either present in person or represented by proxy at the meeting in order for the meeting to be considered valid.

Further enquiries may be directed to either Computershare Investor Services Pty Limited on 1300 850 505 (within Australia) or +61 3 9415 4000 (outside Australia), or a special Unilife Shareholder Information Hotline on 1800 440 201 (within Australia) or +61 2 8256 3392 (outside of Australia).

Meeting resolutions relate to the issuance of CDIs and options to certain professional and sophisticated investors for a Placement of CDIs and free attaching options to raise approximately A$23.1 million, and the issuance of warrants to Keystone Redevelopment Group and L2 Architecture relating to the successful development of the Company's new headquarters and manufacturing facility in Pennsylvania. The meeting will also serve to transact any other business as may properly come before the meeting, or any adjournment or postponement of the meeting.

About Unilife Corporation

Unilife Corporation is a U.S.-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for Unilife products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. These patent-protected syringes incorporate automatic, operator-controlled needle retraction features which are fully integrated within the barrel, and are designed to protect those at risk of needlestick injuries and unsafe injection practices. Unilife is ISO 13485-certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.

This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission. 

General: UNIS-G

SOURCE Unilife Corporation